Please login to the form below

Not currently logged in

lung cancer

This page shows the latest lung cancer news and features for those working in and with pharma, biotech and healthcare.

Imugene’s cancer vaccine shows promise in mid-stage stomach cancer trial

Imugene’s cancer vaccine shows promise in mid-stage stomach cancer trial

The HER-Vaxx jab is a B-cell activating cancer immunotherapy designed to target tumours that overexpress the HER2/neu receptor in gastric, breast, ovarian, lung and pancreatic cancers. ... Elsewhere in Imugene’s pipeline are a phase 1 triple negative

Latest news

More from news
Approximately 111 fully matching, plus 854 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 62 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 16 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need...
JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...